Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$118.76
+0.1%
$114.01
$87.95
$124.43
$2.22B0.86195,151 shs175,357 shs
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$38.47
+1.7%
$40.95
$18.08
$51.60
$2.14B0.9419,293 shs241,952 shs
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
$19.73
+0.4%
$19.70
$13.46
$31.04
$542.87M0.93235,459 shs224,998 shs
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$27.03
+0.6%
$26.32
$15.69
$27.94
$2.20B0.64746,449 shs532,944 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
0.00%+2.78%-0.02%+28.95%+5.00%
Astrana Health, Inc. stock logo
ASTH
Astrana Health
0.00%+1.34%+12.72%+1.26%+25.31%
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
0.00%+0.61%+6.36%+3.03%-10.40%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.00%+1.39%+1.50%+19.47%+62.84%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$118.76
+0.1%
$114.01
$87.95
$124.43
$2.22B0.86195,151 shs175,357 shs
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$38.47
+1.7%
$40.95
$18.08
$51.60
$2.14B0.9419,293 shs241,952 shs
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
$19.73
+0.4%
$19.70
$13.46
$31.04
$542.87M0.93235,459 shs224,998 shs
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$27.03
+0.6%
$26.32
$15.69
$27.94
$2.20B0.64746,449 shs532,944 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
0.00%+2.78%-0.02%+28.95%+5.00%
Astrana Health, Inc. stock logo
ASTH
Astrana Health
0.00%+1.34%+12.72%+1.26%+25.31%
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
0.00%+0.61%+6.36%+3.03%-10.40%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.00%+1.39%+1.50%+19.47%+62.84%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
2.70
Moderate Buy$128.868.50% Upside
Astrana Health, Inc. stock logo
ASTH
Astrana Health
2.78
Moderate Buy$49.4328.49% Upside
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
2.00
Hold$27.5039.38% Upside
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
2.00
Hold$26.60-1.59% Downside

Current Analyst Ratings Breakdown

Latest FLGT, MD, ASTH, and ADUS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/27/2026
Astrana Health, Inc. stock logo
ASTH
Astrana Health
Reiterated RatingHold (C)
8/27/2026
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
UpgradeSell (E+)Sell (D-)
8/25/2026
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
DowngradeBuy (B-)Hold (C+)
8/19/2026
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
DowngradeBuyHold$27.00 ➝ $28.00
8/10/2026
Astrana Health, Inc. stock logo
ASTH
Astrana Health
Boost Price TargetBuy$47.00 ➝ $55.00
8/7/2026
Astrana Health, Inc. stock logo
ASTH
Astrana Health
Boost Price TargetOverweight$50.00 ➝ $53.00
8/6/2026
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
Boost Price TargetNeutral$25.00 ➝ $28.00
8/5/2026
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
Reiterated RatingHold$25.00
8/5/2026
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
Boost Price TargetOutperform$130.00 ➝ $134.00
8/4/2026
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
UpgradeHold (C+)Buy (B-)
8/4/2026
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
Boost Price TargetNeutral$15.00 ➝ $19.00
(Data available from 9/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$1.42B1.56$6.49 per share18.29$61.48 per share1.93
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$3.18B0.67$2.81 per share13.67$15.09 per share2.55
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
$323.93M1.68N/AN/A$36.20 per share0.55
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$1.95B1.13$2.24 per share12.09$10.84 per share2.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$95.91M$5.7020.8417.571.597.13%9.96%7.62%11/2/2026 (Estimated)
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$22.49M$0.8246.9221.37N/A1.05%10.30%3.67%11/5/2026 (Estimated)
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
-$60.51M-$2.82N/AN/AN/A-26.05%-4.93%-4.50%11/6/2026 (Estimated)
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$165.39M$2.0912.9312.12N/A8.96%20.05%8.15%11/2/2026 (Estimated)

Latest FLGT, MD, ASTH, and ADUS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Astrana Health, Inc. stock logo
ASTH
Astrana Health
$0.3358$0.80+$0.4642$0.40$985.62 million$972.52 million
8/4/2026Q2 2026
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$0.5910$0.63+$0.0390$0.49$478.49 million$487.78 million
8/3/2026Q2 2026
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$1.70$1.73+$0.03$1.49$376.24 million$377.41 million
7/30/2026Q2 2026
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
-$0.46-$0.58-$0.12-$1.05$94.00 million$85.39 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
N/AN/AN/AN/AN/A
Astrana Health, Inc. stock logo
ASTH
Astrana Health
N/AN/AN/AN/AN/A
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
N/AN/AN/AN/AN/A
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
0.05
1.69
1.69
Astrana Health, Inc. stock logo
ASTH
Astrana Health
1.05
1.23
1.23
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
N/A
6.34
6.34
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.45
1.32
1.32

Institutional Ownership

CompanyInstitutional Ownership
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
95.35%
Astrana Health, Inc. stock logo
ASTH
Astrana Health
52.77%
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
48.06%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
97.71%

Insider Ownership

CompanyInsider Ownership
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
4.10%
Astrana Health, Inc. stock logo
ASTH
Astrana Health
20.30%
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
36.18%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
1.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
50,65918.67 million17.91 millionOptionable
Astrana Health, Inc. stock logo
ASTH
Astrana Health
3,00055.74 million44.42 millionOptionable
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
1,31527.52 million17.56 millionOptionable
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
4,31581.25 million79.79 millionOptionable

Recent News About These Companies

Analysts Set Pediatrix Medical Group, Inc. (NYSE:MD) Price Target at $25.00
Pediatrix Medical Group (NYSE:MD) Cut to "Buy" at Wall Street Zen
Pediatrix Medical Group stock holds near $26.23

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Addus HomeCare stock logo

Addus HomeCare NASDAQ:ADUS

$118.76 +0.07 (+0.06%)
As of 09/4/2026 04:00 PM Eastern

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

Astrana Health stock logo

Astrana Health NASDAQ:ASTH

$38.47 +0.64 (+1.69%)
As of 09/4/2026 04:00 PM Eastern

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

Fulgent Genetics stock logo

Fulgent Genetics NASDAQ:FLGT

$19.73 +0.08 (+0.41%)
As of 09/4/2026 04:00 PM Eastern

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

Pediatrix Medical Group stock logo

Pediatrix Medical Group NYSE:MD

$27.03 +0.15 (+0.56%)
As of 09/4/2026 03:58 PM Eastern

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.